

Fundamental dimension Equity attribute | ALGMPeer $31.48▼-0.66% Cap $5.87BP/E 388.6x QuantScore52/100 | ADILeader $394.35▼-0.28% Cap $191.1BP/E 46.6x QuantScore67/100 | AMBAPeer $66.50▲+5.35% Cap $2.94BP/E -51.6x QuantScore55/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
25/100 |
70/100 |
71/100 |
Valuation Multiples, PEG & DCF upside | 20/100 | 42/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 75/100 | 77/100 | 88/100 |
Growth Revenue / earnings growth & margins | 59/100 | 64/100 | 61/100 |
Sentiment Analyst ratings, targets & revisions | 83/100 | 84/100 | 58/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 388.6x | 46.6x | -51.6x |
Forward P/E (next FY) | 30.6x | 30.7x | 82.7x |
EV / EBITDA (TTM) | 57.7x | 28.2x | -98.5x |
Price / Sales | 6.2x | 13.8x | 7.0x |
Price / Free Cash Flow | 66.4x | 38.7x | 323.3x |
PEG ratio | 0.72 | 0.41 | -0.97 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 8 / 9 | 5 / 9 |
Altman Z-Score | 8.91 (Safe) | 8.75 (Safe) | 10.57 (Safe) |
Total debt / equity | 0.30 | 0.27 | 0.02 |
Quick ratio | 2.3x | 0.9x | 2.3x |
Interest coverage | 2.2x | 14.1x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +22.8% | +16.9% | +37.2% |
Net income growth YoY | +79.6% | +38.7% | +35.2% |
Gross margin (TTM) | 47.2% | 65.8% | 58.3% |
Operating margin (FY) | 4.8% | 26.6% | -21.1% |
FCF margin (FY) | 14.0% | 38.8% | 14.8% |
5. Trailing price performancePrice change over period |
1M return | -10.4% | +5.0% | -4.8% |
3M return | -31.6% | +5.1% | -2.3% |
6M return | -28.7% | +6.2% | -0.6% |
Year to date | +19.3% | +45.4% | -6.1% |
1Y return | +1.8% | +60.2% | -22.3% |
3Y return | +9.4% | +133.7% | +37.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $3.39 -89.2% premium | $170.08 -56.9% premium | $-22.24 -133.4% premium |
Wall Street consensus target | $54.00 +71.5% · range $45.00–$67.00 | $480.24 +21.8% · range $405.00–$675.00 | $85.50 +28.6% · range $65.00–$106.00 |
Consensus stance | 92% Buy8% Hold0% Sell | 83% Buy17% Hold-0% Sell | 58% Buy39% Hold3% Sell |